ストックスクリーナーアプリを入手
0.7187
0.07%
-0.0005
アフターアワーズ：
.69
-0.0287
-3.99%
前日終値:
$0.7192
開ける：
$0.7
24時間の取引高:
221.35K
Relative Volume:
0.85
時価総額：
$55.23M
収益：
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.7898
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
+1.28%
1か月 パフォーマンス:
-7.88%
6か月 パフォーマンス:
-21.11%
1年 パフォーマンス:
-5.08%
1日の値動き範囲:
$0.6875
$0.7274
1週間の範囲:
$0.6751
$0.7459
52週間の値動き範囲:
$0.5406
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.7187 | 55.27M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Will Cue Biopharma Inc. stock reach all time highs in 2025July 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Reversal indicators forming on Cue Biopharma Inc. stockRate Cut & Technical Pattern Recognition Alerts - newser.com
Is Cue Biopharma Inc. (1UC) stock undervalued after correctionInsider Buying & Real-Time Buy Signal Notifications - newser.com
Cue Biopharma names Usman Azam as new CEO and president - The Pharma Letter
Will breakout in Cue Biopharma Inc. lead to full recoveryTrade Volume Report & Low Risk High Reward Ideas - newser.com
Is Cue Biopharma Inc. stock a top momentum playWeekly Investment Report & Fast Gain Stock Tips - newser.com
Building trade automation scripts for Cue Biopharma Inc.2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Market reaction to Cue Biopharma Inc.’s recent newsMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Cue Biopharma Appoints Usman “Oz” Azam, M.D., as CEO - citybiz
Cue Biopharma Appoints Usman Azam as New CEO - TipRanks
How Cue Biopharma Inc. (1UC) stock stacks up against competitorsMarket Performance Report & Fast Gain Swing Trade Alerts - newser.com
Cue Biopharma, Inc. Appoints Usman ?Oz? Azam, M.D. as President, Effective September 29, 2025 - MarketScreener
Cue Biopharma appoints new CEO, shifts focus to autoimmune therapies - MarketScreener
Cue Biopharma names Usman Azam as new CEO, shifts focus to autoimmune disease - Investing.com
Cue Biopharma appoints Usman Azam as CEO - TipRanks
Cue Biopharma Announces Strategic Transition in Leadership - GlobeNewswire
Former Novartis CAR-T Head Takes Helm at Cue Biopharma to Lead Revolutionary Autoimmune Drug Development - Stock Titan
GC Wealth Management RIA LLC Acquires New Stake in Cue Biopharma, Inc. $CUE - MarketBeat
How to build a custom watchlist for Cue Biopharma Inc.Weekly Volume Report & Risk Managed Investment Strategies - newser.com
What drives Cue Biopharma Inc stock priceBull Market Opportunities & Free High Frequency Trading Ideas - Early Times
Cue Biopharma (NASDAQ:CUE) Trading Up 2.9%What's Next? - MarketBeat
Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role - MSN
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):